Q3 2022 Regulus Therapeutics Inc Earnings Call Transcript

Nov 10, 2022 / 10:00PM GMT
Operator

Hello, and welcome to the Regulus Therapeutics Inc. Q3 2022 Earnings Conference Call. (Operator Instructions)

Please note this event is being recorded.

I would now like to turn the conference over to Chief Financial Officer, Cris Calsada. Please go ahead.

Crispina Calsada - Regulus Therapeutics Inc. - CFO

Thank you, and good afternoon, and thank you for joining us to discuss Regulus Therapeutics third quarter 2022 financial results and corporate highlights.

Joining me on today's call is Jay Hagan, President and Chief Executive Officer; and Dr. Denis Drygin, Chief Scientific Officer. Jay will provide opening remarks and share progress on our ADPKD program, and I will review the financial results before we open the line for questions.

Before we begin, I'd like to remind you that this call will contain forward-looking statements concerning Regulus Therapeutics' future expectations, plans, prospects, corporate strategy and performance, which constitute forward-looking statements for the purposes of the safe harbor provision

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot